Ronak Savla is Director, Strategic Ventures at Catalent Pharma Solutions. In his role, Ronak is responsible for expanding and nurturing the company’s strategic partnerships with life science venture capital firms, biotechnology incubators, consulting firms, and academic technology transfer offices. Previously, Ronak led the Medical Affairs and Competitive Intelligence functions at Innate Pharma, a biotechnology company harnessing the innate immune to develop novel therapeutics. Ronak has a Pharm.D. and Ph.D. from Rutgers University and a M.B.A. from Johns Hopkins University – Carey Business School.